Satyam Pathology Profile
Key Indicators
- Authorised Capital ₹ 1.60 M
as on 31-12-2024
- Paid Up Capital ₹ 1.60 M
as on 31-12-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.56 Cr
as on 31-12-2024
- Satisfied Charges ₹ 3.70 M
as on 31-12-2024
- Revenue 11.80%
(FY 2020)
- Profit -3.15%
(FY 2020)
- Ebitda 81.80%
(FY 2020)
- Net Worth 26.72%
(FY 2020)
- Total Assets 8.00%
(FY 2020)
About Satyam Pathology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 M and a paid-up capital of Rs 1.60 M.
The company currently has active open charges totaling ₹1.56 Cr. The company has closed loans amounting to ₹3.70 M, as per Ministry of Corporate Affairs (MCA) records.
Anubha, Ashok Kumar, and Pankaj Kumar serve as directors at the Company.
- CIN/LLPIN
U85191UP2010PTC039423
- Company No.
039423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Satyam Pathology?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anubha  | Director | 02-Feb-2010 | Current |
| Ashok Kumar | Director | 02-Feb-2010 | Current |
| Pankaj Kumar | Director | 02-Feb-2010 | Current |
Financial Performance of Satyam Pathology.
Satyam Pathology Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.8% increase. The company also saw a slight decrease in profitability, with a 3.15% decrease in profit. The company's net worth Soared by an impressive increase of 26.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satyam Pathology?
In 2020, Satyam Pathology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 14 Dec 2022 | ₹0.28 M | Open |
Others Creation Date: 04 Jul 2020 | ₹1.40 M | Open |
Others Creation Date: 10 Oct 2018 | ₹6.40 M | Open |
How Many Employees Work at Satyam Pathology?
Satyam Pathology has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyam Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyam Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
